General Federal Contracts — April 29, 2026

HHS/BARDA awarded Basilea a $92,501,232 cost-sharing contract on 2024-09-18 for antimicrobials R&D against resistant infections, with $36.2M outlayed and potential extension to 2035-12-31 under full and open competition.

NASA Goddard awarded LJT & Associates $94,578,354 in 2016 for Wallops Island launch operations, but only $8,769,312 outlayed by end of performance period August 2019, signaling limited ongoing revenue without follow-ons.

Department of State awarded IDEMIA $72,032,459 in 2018 for visa/passport facial recognition integration, with $18,176,969 outlayed through ongoing performance to 2026-09-29 under firm fixed price terms.

Basilea Pharmaceutica International Ltd's $92.5M BARDA contract carries R&D execution risks through milestones to 2031-09-30 or 2035-12-31, with only $36.2M outlayed to date.

LJT & Associates' $94.6M NASA contract has only $8.8M outlayed against obligation post-2019 end, indicating potential non-realization of full value without follow-ons.

IDEMIA National Security Solutions' $72M State Dept contract faces high firm fixed-price risk with only $18.2M outlayed midway to 2026-09-29.

Basilea Pharmaceutica International Ltd has upside from unexercised options on $92.5M BARDA contract to $267.6M ceiling for antimicrobials R&D.

Potential follow-on to LJT & Associates' expired $94.6M NASA Goddard contract for Wallops Island launch operations.

IDEMIA National Security Solutions could realize remaining $54M obligation on State Dept facial recognition order through 2026.

HHS/BARDA's $92.5M award to Basilea Pharmaceutica International Ltd underscores commitment to antimicrobials for resistant infections, with long 7-11 year horizon.

NASA Goddard's $94.6M non-competed contract to LJT & Associates for Wallops launch support ended 2019 with low outlay, signaling need for follow-ons.

Department of State's $72M firm fixed-price order to IDEMIA for facial recognition in visa/passport processes provides multi-year visibility to 2026.

{"entity"=>"Basilea Pharmaceutica International Ltd", "reason"=>"$92.5M BARDA contract with $267.6M ceiling and $36.2M outlayed", "trigger"=>"option exercises toward 2035-12-31"}

{"entity"=>"LJT & Associates, Inc.", "reason"=>"$94.6M NASA obligation with only $8.8M outlayed post-2019 end", "trigger"=>"follow-on contract awards"}

{"entity"=>"IDEMIA National Security Solutions LLC", "reason"=>"$72M State Dept order with $18.2M outlayed to 2026-09-29", "trigger"=>"outlay progress and option exercises to $74.1M"}